We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





The COVID-19 Pandemic: Primed and Prepared

By CLN Stat
Posted on 14 Dec 2020
Print article
Illustration
Illustration
Late-breaking scientific sessions detail the testing and response landscape, latest science on SARS-CoV-2 virology and therapeutics, quest for vaccines, more effective mobilization against new global health threats.

Seven late-breaking sessions at the 2020 AACC Annual Scientific Meeting & Clinical Lab Expo address the game-changing topic of SARS-CoV-2, exploring the virology and characteristics of this novel virus and the recent landscape of testing and therapeutics. “Each of these scientific sessions will provide attendees a much deeper understanding of the COVID-19 pandemic and shed light on the advantages and disadvantages of the various tests that are being performed for SARS-CoV-2, from molecular to serology,” Paul Jannetto, PhD, DABCC, FAACC, chair of the Annual Meeting Organizing Committee (AMOC), told CLN Stat.

Participants will gain a deeper comprehension of how this virus differs from others and of current treatment strategies.

The postponement of the 2020 Annual Scientific Meeting & Clinical Lab Expo from July to December underscored the importance of providing the latest scientific information on the COVID-19 pandemic, said Jannetto. AMOC wanted to highlight timely and novel research on antibody/antigen testing, therapeutic strategies, and the latest information about a vaccine against SARS-CoV-2.

The panel also wanted to include a general session on virology and diagnostic paradigms, supply chain and laboratory testing issues, and the role of clinical labs in global pandemics. “As a result, the AMOC actively recruited experts in each of these areas who graciously agreed to provide attendees the cutting-edge scientific information around each of these relevant topics,” said Jannetto.

In a special session on Tuesday, December 15, Assistant Secretary of Health Adm. Brett P. Giroir, MD, who coordinates SARS-CoV-2 testing efforts across the Department of Health and Human Services, will discuss the past, present, and future of SARS-CoV-2. This session will take place from 4:30–5:30 p.m. (U.S. Central Standard Time)

Jannetto is also looking forward to the Chair’s Invited Session this year, Pandemic Preparedness: The Role of Clinical Laboratories and Public Health in Controlling Outbreaks Representing a Global Health Threat. His colleague Matthew Binnicker, PhD, director of clinical virology at Mayo Clinic, will be talking about the role of clinical labs and public health in controlling global outbreaks and what laboratories can do to be better prepared for the next pandemic. This presentation takes place on Monday, December 14, from 11 a.m.–12:30 p.m.

Related Links:
2020 AACC Annual Scientific Meeting & Clinical Lab Expo
Annual Meeting Organizing Committee
Pandemic Preparedness: The Role of Clinical Laboratories and Public Health in Controlling Outbreaks Representing a Global Health Threat
New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Molecular Diagnostics

view channel
Image: Researchers have found the first evidence of testing for the alpha-synuclein protein in blood samples via seed amplification assay (Photo courtesy of Shutterstock)

Blood Test to Detect Alpha-Synuclein Protein Could Revolutionize Parkinson's Disease Diagnostics

Currently, Parkinson's disease (PD) is identified through clinical diagnosis, typically at a later stage in the disease's progression. There is a pressing need for an objective and quantifiable biomarker... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: Ultra-Rapid Antimicrobial Susceptibility Testing (uRAST) revolutionizing traditional antibiotic susceptibility testing (Photo courtesy of Seoul National University)

Ultra-Rapid Culture-Free Sepsis Test Reduces Testing Time from Days to Hours

Sepsis, a critical emergency condition, results from an overactive inflammatory response to pathogens like bacteria or fungi in the blood, leading to organ damage and the possibility of sudden death.... Read more

Pathology

view channel
Image: The AI model can distinguish different stages of DCIS from inexpensive and readily available breast tissue images (Photo courtesy of David A. Litman/Shutterstock)

AI Model Identifies Breast Tumor Stages Likely To Progress to Invasive Cancer

Ductal carcinoma in situ (DCIS) is a non-invasive type of tumor that can sometimes progress to a more lethal form of breast cancer and represents about 25% of all breast cancer cases. Between 30% and 50%... Read more

Industry

view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.